JA2-WP5 EUnetHTA Joint Action 2 (2012-15)
2013 - PDF

The purpose of the assessment is to assess the effectiveness and safety of renal denervation systems for patients who suffer from treatment-resistant hypertension compared to standard of care (no treatment, additional pharmacological treatment, device-based hypertension therapy and sham treatment).

Final version of the assessment was published in December 2013

Below is the documentation provided by the Joint Assessment authoring team:

Project plan
Summary document of comments and author’s replies to the review